Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary AtherosclerosisYoshihiro Noji, Hiroshi Mabuchi, Junji Koizumi et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2001Cited by 151
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutationHiroshi Mabuchi, Junji Koizumi, Atsushi Nohara et al.|Atherosclerosis|2014Cited by 87
Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemiaYoshihiro Noji, Hiroshi Mabuchi, Toshinori Higashikata et al.|Atherosclerosis|2002Cited by 74
Impact of Severe Earthquake on the Occurrence of Acute Coronary Syndrome and Stroke in a Rural Area of Japan Experience From the Noto Peninsula EarthquakeMasayuki Tsuchida, Masakazu Yamagishi, Masa‐aki Kawashiri et al.|Circulation Journal|2009Cited by 57
Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemiaJunji Koizumi, Satoshi Takada, Ichiro Koizumi et al.|Atherosclerosis|1993Cited by 41